The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2017
Filed:
Sep. 06, 2013
Applicants:
Adelaide Research & Innovation Pty Ltd, Adelaide, AU;
Peter Maccallum Cancer Institute, East Melbourne, Victoria, AU;
Inventors:
Shaun Reuss Mccoll, Myrtle Bank, AU;
Ian Comerford, Glenalta, AU;
Yuka Harata-Lee, Greenwith, AU;
Mark Smyth, Kelvin Grove, AU;
Assignees:
Adelaide Research & Innovation PTY LTD, South Australia, AU;
Peter Maccallum Cancer Institute, Victoria, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C12N 15/11 (2006.01); C07K 16/30 (2006.01); A61K 31/7105 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3053 (2013.01); A61K 31/7105 (2013.01); C07K 16/2866 (2013.01); C07K 16/30 (2013.01); C12N 15/1138 (2013.01); G01N 33/5011 (2013.01); A61K 2039/505 (2013.01); C07K 2317/34 (2013.01); C07K 2317/73 (2013.01); C12N 2310/14 (2013.01);
Abstract
The present disclosure relates to the prevention and/or treatment of metastatic cancer. Certain example embodiments of the present disclosure provide a method for preventing and/or treating a metastatic cancer in a subject. The method comprises administering to the subject a therapeutically effective amount of an inhibitor of a chemokine receptor CCX-CKR.